Chammas & Marcheteau advised Yotta Capital Partners on its acquisition of a majority stake in SEDI-ATI. Yotta Capital Partners, the leading French investment fund dedicated to...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Bpifrance, Quantonation, Supernova Invest and Innovacom on their participation in Quobly’s fundraising. Quobly, formerly known as Siquance, a company specialized in the...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised a consortium of investment funds. The sellers were advised by Lamartine Conseil. The management was advised by Lamartine Conseil. The senior lenders...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Extens on the acquisition (majority LBO). Extens, a renowned digital health fund, has announced the acquisition of a majority stake in Val...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Xelya and the sellers in the framework of the OBO. Goodwin and MB Avocats advised Parquest. The founders of Xelya, together with...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal while Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund, Panacea Venture, and...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal. Lavery de Billy and Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund,...
You must be a Standard 1 Year member to access this content.
